This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beecham Corporation. Active years: 2004.
Company Filing History:
Years Active: 2004
Title: Siegfried B Christensen: Innovator in Fatty Acid Synthase Inhibition
Introduction
Siegfried B Christensen is a notable inventor based in King of Prussia, PA (US). He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for fatty acid synthase. His work has implications for various therapeutic applications.
Latest Patents
Siegfried holds a patent for "Fatty acid synthase inhibitors." This invention relates to the use of compounds as inhibitors of the fatty acid synthase FabH. His innovative approach has the potential to impact the treatment of metabolic disorders.
Career Highlights
Siegfried is associated with SmithKline Beecham Corporation, where he has been involved in groundbreaking research. His expertise in biochemistry and pharmacology has led to advancements in drug development.
Collaborations
Throughout his career, Siegfried has collaborated with talented individuals such as Jia-Ning Xiang and Daniel J Mercer. These partnerships have fostered a productive research environment, enhancing the quality and impact of their work.
Conclusion
Siegfried B Christensen's contributions to the field of fatty acid synthase inhibition exemplify the importance of innovation in biochemistry. His work continues to inspire future research and development in this critical area.